A.A.S. Reis, D.M. Silva, M.P. Curado and A.D. da Cruz
Published November 16, 2010
Genet. Mol. Res. 9 (4): 2222-2229 (2010)
DOI 10.4238/vol9-4gmr807

About the Authors
A.A.S. Reis, D.M. Silva, M.P. Curado and A.D. da Cruz

Corresponding author: 
A.A.S. Reis
E-mail: angeladamski@gmail.com

ABSTRACT

Specific genotypes appear to be related to the development of thyroid disease. We examined whether polymorphisms of the genes CYP1A1, GSTM1, GSTT1, and TP53 at codon 72 are associated with increased risk for thyroid nodules. Blood samples were obtained from 122 thyroid patients with nodules and from 134 healthy control individuals from Goiânia city, GO, Brazil. We found no significant association of CYP1A1m1 and CYP1A1m2 genotypes with thyroid diseases (P > 0.05). The null genotypes of GSTM1 and GSTT1 genes were predominant in patients with nodules, indicating that individuals that possess these genotypes have a predisposition for thyroid disease. The genotype p53Arg Arg was associated with a low risk for thyroid cancer (OR = 0.15; P < 0.0001), indicating that the arginine allele in homozygosis could have a protective effect against carcinogenesis. On the other hand, the p53ArgPro genotype was significantly associated with malignant neoplastic nodules (OR = 3.65; P = 0.001). Interindividual variation in susceptibility to thyroid diseases could provide new perspectives for early diagnosis, prognosis and treatment, indicating which patients with thyroid nodules will benefit from treatment, depending on specific polymorphic profiles.

Key words: Polymorphism, Thyroid disease, Susceptibility, p53, CYP, GST.